Get started
Author

Kosar Ghasemi

Observed name: Kimia Ghasemi
ORCID: 0000-0001-5837-6148
Observed ORCID: 0000-0001-5837-6148
OpenAlex ID: A5026890276
Tiragolumab and TIGIT: pioneering the next era of cancer immunotherapy
2025 · Kosar Ghasemi · Frontiers in Pharmacology · 32
PDF
A Brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies
2021 · Kimia Ghasemi, Kimia Ghasemi, et al. · European Journal of Pharmacology · 30
Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential
2022 · Kimia Ghasemi, Kimia Ghasemi, et al. · Journal of Clinical Pharmacy and Therapeutics · 17
MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?
2022 · Kimia Ghasemi, Kimia Ghasemi, et al. · International Immunopharmacology · 13
Gamma-Tocopherol Enhances Apoptotic Effects of Lovastatin in Human Colorectal Carcinoma Cell Line (HT29)
2014 · Mohsen Rezaei, Leila Zeidooni, et al. · Nutrition and Cancer · 11
C–C motif glycoprotein ligand 5 (CCL5) and its GPCR CCR5: Macromolecular game-changers in cancer biology
2025 · Kosar Ghasemi · International Journal of Biological Macromolecules · 10
Targeting LAG-3: Relatlimab, Fianlimab, and ieramilimab reshape the landscape of cancer combination immunotherapy
2025 · Kosar Ghasemi · Pathology - Research and Practice · 4
"Umma", Beyond Civilization in the Quranic View
2019 · fathieh fattahizadeh, Kosar Ghasemi, et al. · Zenodo (CERN European Organization for Nuclear Research)
PDF
Works count: 8
Citation count: 117
H-index: 6
I10-index: 6
Year
Topic
Type